Investigating the clinical efficacy and mechanism of Runfei Huayu recipe in treating connective tissue disease merger interstitial lung disease based on Th17/Treg glycolytic pathway
- Conditions
- Connective tissue disease merger interstitial lung disease
- Registration Number
- ITMCTR2200006523
- Lead Sponsor
- Taizhou Hospital of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the diagnostic criteria of traditional Chinese and western medicine for CTD-ILD;
2. 35 years = age =75 years, male or female;
3. This study was approved by the ethics committee of our hospital, and informed consent was obtained from patients with signed informed consent;
4. No fertility requirement.
1. Patients with pulmonary tuberculosis, chronic obstructive pulmonary disease, emphysema, bronchiectasis, lung tumors, silicosis, pneumoconiosis and other lung diseases;
2. Patients with some serious primary diseases, such as digestive, respiratory, cardiovascular, hematopoietic and nervous system diseases, mental diseases, etc.;
3. Abnormal liver and kidney function, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) exceeding 1.5 times the normal value, blood creatinine (Scr) and urea nitrogen (BUN) any higher than the normal value;
4. Allergic constitution and allergic to clinical study medication;
5. Women who are during pregnancy, preparing for pregnancy, or during breastfeeding period.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method